Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366158112> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W4366158112 abstract "The aetiology of Parkinson s disease PD has been linked to the aggregation and spread of misfolded alpha synuclein via the gut-brain axis. We previously reported the effects of a biological response modifier, beta glucan, produced by the AFO 202 strain of Aureobasidium Pullulans, which improves clinical symptoms and controls gut Enterobacteriaceae associated with curli and amyloid alpha synuclein production. In this study, we report the effects of beta-glucan on PD. Eight patients with PD were recruited, five of whom completed the study. Each participant was administered 3 g of AFO-202 B glucan orally daily for 90 days in addition to their regular prescription drugs. Pre and post study comparison revealed that the mean UPDRS decreased from 43.25 at baseline to 40 post intervention. Improvements in cognition, walking and balance, postural stability, and constipation scales were observed. The mean constipation severity score decreased from 3 to 1.75 post intervention. The serum creatinine kinase levels decreased and the blood glucose and lipid levels normalised. The MRI Parkinson s index MRPI improved in one patient. This safe AFO 202 B glucan produced beneficial diseasemodifying improvements in the UPDRS and MRI that were clinically significant in the short timeframe of 90 days. Further validation in larger, longer-term clinical trials will help confirm the use of beta glucan as a potential adjuvant treatment for PD which may pave way for future evaluations of these beta glucans in other synculeinopathies as well Lewy body related pathogenesis." @default.
- W4366158112 created "2023-04-19" @default.
- W4366158112 creator A5000253965 @default.
- W4366158112 creator A5007176086 @default.
- W4366158112 creator A5020306223 @default.
- W4366158112 creator A5022155485 @default.
- W4366158112 creator A5024237038 @default.
- W4366158112 creator A5037348915 @default.
- W4366158112 creator A5043676052 @default.
- W4366158112 creator A5060518312 @default.
- W4366158112 creator A5068840411 @default.
- W4366158112 creator A5088537100 @default.
- W4366158112 date "2023-04-17" @default.
- W4366158112 modified "2023-09-28" @default.
- W4366158112 title "Evaluation of the disease modifying effects of Aureobasidium pullulans AFO 202 strain produced Beta Glucan in Parkinsons disease Results of a pilot clinical study" @default.
- W4366158112 doi "https://doi.org/10.1101/2023.04.14.23288571" @default.
- W4366158112 hasPublicationYear "2023" @default.
- W4366158112 type Work @default.
- W4366158112 citedByCount "0" @default.
- W4366158112 crossrefType "posted-content" @default.
- W4366158112 hasAuthorship W4366158112A5000253965 @default.
- W4366158112 hasAuthorship W4366158112A5007176086 @default.
- W4366158112 hasAuthorship W4366158112A5020306223 @default.
- W4366158112 hasAuthorship W4366158112A5022155485 @default.
- W4366158112 hasAuthorship W4366158112A5024237038 @default.
- W4366158112 hasAuthorship W4366158112A5037348915 @default.
- W4366158112 hasAuthorship W4366158112A5043676052 @default.
- W4366158112 hasAuthorship W4366158112A5060518312 @default.
- W4366158112 hasAuthorship W4366158112A5068840411 @default.
- W4366158112 hasAuthorship W4366158112A5088537100 @default.
- W4366158112 hasBestOaLocation W43661581121 @default.
- W4366158112 hasConcept C100544194 @default.
- W4366158112 hasConcept C126322002 @default.
- W4366158112 hasConcept C2779134260 @default.
- W4366158112 hasConcept C2779454560 @default.
- W4366158112 hasConcept C2779734285 @default.
- W4366158112 hasConcept C2781112942 @default.
- W4366158112 hasConcept C31903555 @default.
- W4366158112 hasConcept C535046627 @default.
- W4366158112 hasConcept C71924100 @default.
- W4366158112 hasConcept C86803240 @default.
- W4366158112 hasConcept C90924648 @default.
- W4366158112 hasConceptScore W4366158112C100544194 @default.
- W4366158112 hasConceptScore W4366158112C126322002 @default.
- W4366158112 hasConceptScore W4366158112C2779134260 @default.
- W4366158112 hasConceptScore W4366158112C2779454560 @default.
- W4366158112 hasConceptScore W4366158112C2779734285 @default.
- W4366158112 hasConceptScore W4366158112C2781112942 @default.
- W4366158112 hasConceptScore W4366158112C31903555 @default.
- W4366158112 hasConceptScore W4366158112C535046627 @default.
- W4366158112 hasConceptScore W4366158112C71924100 @default.
- W4366158112 hasConceptScore W4366158112C86803240 @default.
- W4366158112 hasConceptScore W4366158112C90924648 @default.
- W4366158112 hasLocation W43661581121 @default.
- W4366158112 hasOpenAccess W4366158112 @default.
- W4366158112 hasPrimaryLocation W43661581121 @default.
- W4366158112 hasRelatedWork W1606821450 @default.
- W4366158112 hasRelatedWork W2017568864 @default.
- W4366158112 hasRelatedWork W22299808 @default.
- W4366158112 hasRelatedWork W2394573997 @default.
- W4366158112 hasRelatedWork W2800938491 @default.
- W4366158112 hasRelatedWork W2811494262 @default.
- W4366158112 hasRelatedWork W3003022248 @default.
- W4366158112 hasRelatedWork W3137907604 @default.
- W4366158112 hasRelatedWork W4283788080 @default.
- W4366158112 hasRelatedWork W4362506662 @default.
- W4366158112 isParatext "false" @default.
- W4366158112 isRetracted "false" @default.
- W4366158112 workType "article" @default.